Biocompatible Nanoparticle Technology Being Used to Develop Cancer Therapies & Rapid Diagnostics
Sona’s unique gold nanorods have the potential to power the next generation of lateral flow diagnostics and play a key role in the advancement of impactful scientific and medical applications
Available for Mac, Windows, Chrome, and iOS.
Upcoming Webinars
Medical Webinar
Sun, Apr 21st 2024 1pm EDT
This webinar will focus on the therapy’s scientific premises and pre-clinical interim study data results, as well as the clinical potential of using Sona’s nanotechnology to shrink tumors and better enable immunotherapies.
Investor Webinar
Mon, Apr 22nd 2024 1pm EDT
This webinar will focus on providing an overview of Sona’s Targeted Hyperthermia Therapy, its preclinical development path and its market potential.
Recent Webinars
Technology
Sona Gold Nanorod ("GNR") Technology
Uniquely biocompatible.
Unlocking of in-vivo medical applications potential
Applications
Targeted Hyperthermia Therapy
Sona GNRs in targeted hyperthermia may create the
opportunity to treat cancer without doing significant harm to healthy cells.
Concussion Tests
Sona’s concussion screening test to be used at the scene of injury
Bovine Tuberculosis Tests
Early detection at low cost without the need for test-and-slaughter
Latest News Releases
- April 12, 2024
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study
- March 1, 2024
Market Coverage Report
Report by:
Dated: